Duloxetine related binge eating behaviors: A case report

[1]  S. Pallanti,et al.  Successful duloxetine treatment of a binge eating disorder: a case report , 2010, Journal of psychopharmacology.

[2]  P. Leombruni,et al.  Duloxetine in obese binge eater outpatients: preliminary results from a 12‐week open trial , 2009, Human psychopharmacology.

[3]  M. Cowley,et al.  Catecholamine Reuptake Inhibition Causes Weight Loss by Increasing Locomotor Activity and Thermogenesis , 2008, Neuropsychopharmacology.

[4]  F. López-Muñoz,et al.  Reboxetine Combination in Treatment-resistant Depression to Selective Serotonin Reuptake Inhibitors , 2007, Pharmacopsychiatry.

[5]  M. Fava,et al.  Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report , 2006, Journal of psychopharmacology.

[6]  F. Bymaster,et al.  Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats , 2003, Neuropharmacology.

[7]  A. Rissanen,et al.  Reduced serotonin transporter binding in binge eating women , 2001, Psychopharmacology.

[8]  P. Wellman.  Norepinephrine and the control of food intake. , 2000, Nutrition.

[9]  S. Leibowitz,et al.  Hypothalamic serotonin in control of eating behavior, meal size, and body weight , 1998, Biological Psychiatry.

[10]  T. Brewerton,et al.  Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. , 1992, Archives of general psychiatry.

[11]  W. Kaye,et al.  Neurochemistry of bulimia nervosa. , 1991, The Journal of clinical psychiatry.

[12]  A. Capasso,et al.  Recent clinical aspects of eating disorders. , 2009, Reviews on recent clinical trials.